These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18191391)

  • 1. Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer.
    Linna A; Korhonen M; Mannermaa JP; Airaksinen M; Juppo AM
    Eur J Pharm Biopharm; 2008 Jun; 69(2):786-92. PubMed ID: 18191391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences of using the GMP audit preparation tool in pharmaceutical contract manufacturer audits.
    Linna A; Korhonen M; Airaksinen M; Juppo AM
    Drug Dev Ind Pharm; 2010 Jun; 36(6):632-7. PubMed ID: 19968557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Delphi validation of instrument for the preparation of a GMP audit of a cosmetic contract manufacturer in the UAE.
    Jairoun AA; Al-Hemyari SS; Shahwan M; El-Dahiyat F; Bisgwa J; Jamshed S; Shourrab HY
    Sci Rep; 2022 Jul; 12(1):11265. PubMed ID: 35789167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-based auditing process for pharmaceutical manufacturers.
    Vargo S; Dana B; Rangavajhula V; Rönninger S
    PDA J Pharm Sci Technol; 2014; 68(2):104-12. PubMed ID: 24668599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical GMP: past, present, and future--a review.
    Patel KT; Chotai NP
    Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-based approach to scheduling audits.
    Rönninger S; Holmes M
    PDA J Pharm Sci Technol; 2009; 63(6):575-88. PubMed ID: 20169864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews.
    Hagen NA; Stiles C; Nekolaichuk C; Biondo P; Carlson LE; Fisher K; Fainsinger R
    J Pain Symptom Manage; 2008 Feb; 35(2):136-52. PubMed ID: 18178370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and content validation of an assessment tool for medicine compounding on hospital wards.
    Suvikas-Peltonen E; Granfors E; Celikkayalar E; Laaksonen R; Palmgren J; Airaksinen M
    Int J Clin Pharm; 2016 Dec; 38(6):1457-1463. PubMed ID: 27817169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PICS: pharmaceutical inspection cooperation scheme].
    Morénas J
    Ann Pharm Fr; 2009 Jan; 67(1):16-9. PubMed ID: 19152846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting GMP implementation: developing training materials for the international audience.
    Morimoto K; Curry J; Kopp S; Rägo L; van Zyl A; Wondemagegnehu E; Quick J; Suzuki Y
    Qual Assur; 2003; 10(1):11-27. PubMed ID: 12746156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system].
    Ba A; Courcambeck A; Degui H
    Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
    Anyakora C; Ekwunife O; Alozie F; Esuga M; Ukwuru J; Onya S; Nwokike J
    BMC Health Serv Res; 2017 Sep; 17(1):665. PubMed ID: 28923044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2003; 908():i-viii, 1-136, back cover. PubMed ID: 12768889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.